NCT01140204View on ClinicalTrials.gov

Short-Term Exposure to Lipophilic Anti-proliferative Drugs Delivered by Angiographic Contrast Media

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Coronary Artery Disease
Interventions
DEVICE

Implantation of a bare metal stent

Bare Metal Stent

Trial Locations (2)

10117

Charite University Hospital, Berlin

66421

University Hospital of Saarland, Homburg/Saar

All Listed Sponsors
lead

University Hospital, Saarland

OTHER

NCT01140204 - Short-Term Exposure to Lipophilic Anti-proliferative Drugs Delivered by Angiographic Contrast Media | Biotech Hunter | Biotech Hunter